vs
Alector, Inc.（ALEC）与CADIZ INC（CDZI）财务数据对比。点击上方公司名可切换其他公司
Alector, Inc.的季度营收约是CADIZ INC的1.2倍（$6.2M vs $5.1M），CADIZ INC同比增速更快（7.0% vs -88.5%），CADIZ INC自由现金流更多（$-8.2M vs $-184.1M），过去两年CADIZ INC的营收复合增速更高（113.0% vs -37.4%）
Alector是一家临床阶段生物制药企业，专注于神经退行性疾病的免疫疗法研发，管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求，主要在美国运营，与全球药企合作推进候选药物的临床试验。
Cadiz Inc是一家总部位于美国的自然资源与可持续发展企业，核心业务包括水资源管理、农业用地运营及可再生能源项目开发，主要在加利福尼亚州开展业务，为市政、农业及商业客户提供稳定的供水解决方案与土地管护服务。
ALEC vs CDZI — 直观对比
营收规模更大
ALEC
是对方的1.2倍
$5.1M
营收增速更快
CDZI
高出95.5%
-88.5%
自由现金流更多
CDZI
多$175.8M
$-184.1M
两年增速更快
CDZI
近两年复合增速
-37.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $5.1M |
| 净利润 | — | — |
| 毛利率 | — | 33.0% |
| 营业利润率 | — | -145.4% |
| 净利率 | — | — |
| 营收同比 | -88.5% | 7.0% |
| 净利润同比 | -1696.9% | — |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALECCDZI
| Q4 25 | $6.2M | $5.1M | ||
| Q3 25 | $3.3M | $4.1M | ||
| Q2 25 | $7.9M | $4.1M | ||
| Q1 25 | $3.7M | $3.0M | ||
| Q4 24 | $54.2M | $4.8M | ||
| Q3 24 | $15.3M | $3.2M | ||
| Q2 24 | $15.1M | $513.0K | ||
| Q1 24 | $15.9M | $1.1M |
净利润ALECCDZI
| Q4 25 | — | — | ||
| Q3 25 | $-34.7M | $-7.1M | ||
| Q2 25 | $-30.5M | $-7.7M | ||
| Q1 25 | $-40.5M | $-9.6M | ||
| Q4 24 | $-2.1M | — | ||
| Q3 24 | $-42.2M | $-6.8M | ||
| Q2 24 | $-38.7M | $-8.9M | ||
| Q1 24 | $-36.1M | $-6.8M |
毛利率ALECCDZI
| Q4 25 | — | 33.0% | ||
| Q3 25 | — | 27.3% | ||
| Q2 25 | — | 35.4% | ||
| Q1 25 | — | 29.7% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 25.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 10.4% |
营业利润率ALECCDZI
| Q4 25 | — | -145.4% | ||
| Q3 25 | -1153.6% | -118.0% | ||
| Q2 25 | -433.6% | -140.0% | ||
| Q1 25 | -1216.5% | -255.0% | ||
| Q4 24 | -13.4% | -139.5% | ||
| Q3 24 | -315.7% | -147.9% | ||
| Q2 24 | -302.4% | -1354.6% | ||
| Q1 24 | -275.0% | -437.8% |
净利率ALECCDZI
| Q4 25 | — | — | ||
| Q3 25 | -1063.4% | -170.5% | ||
| Q2 25 | -387.7% | -187.3% | ||
| Q1 25 | -1101.6% | -324.7% | ||
| Q4 24 | -3.8% | — | ||
| Q3 24 | -275.2% | -210.7% | ||
| Q2 24 | -256.4% | -1729.4% | ||
| Q1 24 | -227.0% | -611.1% |
每股收益（稀释后）ALECCDZI
| Q4 25 | — | — | ||
| Q3 25 | $-0.34 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.41 | — | ||
| Q4 24 | $-0.02 | — | ||
| Q3 24 | $-0.43 | — | ||
| Q2 24 | $-0.40 | — | ||
| Q1 24 | $-0.38 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.0M | $8.6M |
| 总债务越低越好 | $10.0M | $72.7M |
| 股东权益账面价值 | $30.6M | $23.3M |
| 总资产 | $293.2M | $140.9M |
| 负债/权益比越低杠杆越低 | 0.33× | 3.13× |
8季度趋势，按日历期对齐
现金及短期投资ALECCDZI
| Q4 25 | $256.0M | $8.6M | ||
| Q3 25 | $291.1M | $4.4M | ||
| Q2 25 | $307.3M | $13.2M | ||
| Q1 25 | $354.6M | $21.6M | ||
| Q4 24 | $413.4M | $17.3M | ||
| Q3 24 | $457.2M | $3.3M | ||
| Q2 24 | $503.3M | $10.1M | ||
| Q1 24 | $562.1M | $19.2M |
总债务ALECCDZI
| Q4 25 | $10.0M | $72.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $10.0M | $56.7M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ALECCDZI
| Q4 25 | $30.6M | $23.3M | ||
| Q3 25 | $57.7M | $27.7M | ||
| Q2 25 | $71.2M | $35.6M | ||
| Q1 25 | $94.6M | $44.0M | ||
| Q4 24 | $126.8M | $34.0M | ||
| Q3 24 | $118.9M | $20.7M | ||
| Q2 24 | $150.6M | $27.6M | ||
| Q1 24 | $178.9M | $36.6M |
总资产ALECCDZI
| Q4 25 | $293.2M | $140.9M | ||
| Q3 25 | $335.3M | $128.0M | ||
| Q2 25 | $356.4M | $136.4M | ||
| Q1 25 | $408.3M | $145.6M | ||
| Q4 24 | $468.3M | $134.5M | ||
| Q3 24 | $516.0M | $112.6M | ||
| Q2 24 | $570.7M | $118.1M | ||
| Q1 24 | $635.5M | $118.1M |
负债/权益比ALECCDZI
| Q4 25 | 0.33× | 3.13× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.08× | 1.67× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-184.0M | $-6.9M |
| 自由现金流经营现金流 - 资本支出 | $-184.1M | $-8.2M |
| 自由现金流率自由现金流/营收 | -2951.3% | -162.2% |
| 资本支出强度资本支出/营收 | 0.7% | 26.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-326.5M | $-26.5M |
8季度趋势，按日历期对齐
经营现金流ALECCDZI
| Q4 25 | $-184.0M | $-6.9M | ||
| Q3 25 | $-32.5M | $-7.0M | ||
| Q2 25 | $-49.0M | $-1.4M | ||
| Q1 25 | $-60.8M | $-3.6M | ||
| Q4 24 | $-55.0M | $-6.2M | ||
| Q3 24 | $-50.7M | $-5.4M | ||
| Q2 24 | $-62.8M | $-7.1M | ||
| Q1 24 | $-61.3M | $-2.9M |
自由现金流ALECCDZI
| Q4 25 | $-184.1M | $-8.2M | ||
| Q3 25 | $-32.5M | $-7.5M | ||
| Q2 25 | $-49.1M | $-5.9M | ||
| Q1 25 | $-60.8M | $-4.9M | ||
| Q4 24 | $-55.2M | $-6.6M | ||
| Q3 24 | $-50.9M | $-5.4M | ||
| Q2 24 | $-63.1M | $-7.3M | ||
| Q1 24 | $-61.9M | $-3.1M |
自由现金流率ALECCDZI
| Q4 25 | -2951.3% | -162.2% | ||
| Q3 25 | -997.6% | -179.8% | ||
| Q2 25 | -623.0% | -142.2% | ||
| Q1 25 | -1655.0% | -167.0% | ||
| Q4 24 | -101.8% | -139.4% | ||
| Q3 24 | -332.1% | -168.8% | ||
| Q2 24 | -418.6% | -1431.6% | ||
| Q1 24 | -389.3% | -272.9% |
资本支出强度ALECCDZI
| Q4 25 | 0.7% | 26.1% | ||
| Q3 25 | 0.3% | 10.8% | ||
| Q2 25 | 0.1% | 109.3% | ||
| Q1 25 | 0.5% | 43.6% | ||
| Q4 24 | 0.3% | 8.7% | ||
| Q3 24 | 1.4% | 1.7% | ||
| Q2 24 | 2.2% | 54.8% | ||
| Q1 24 | 3.4% | 16.6% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALEC
暂无分部数据
CDZI
| Water Treatment | $4.4M | 86% |
| Other | $724.0K | 14% |
